Research ExplorerPublicationsTestosterone-Lowering Medication and Its Association With Re...

Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses

Standard

Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses. / Sauter, Julia; Turner, Daniel; Briken, Peer; Rettenberger, Martin.

In: SEX ABUSE-J RES TR, Vol. 33, No. 4, 06.2021, p. 475-500.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Sauter, J, Turner, D, Briken, P & Rettenberger, M 2021, 'Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses', SEX ABUSE-J RES TR, vol. 33, no. 4, pp. 475-500. https://doi.org/10.1177/1079063220910723

APA

Sauter, J., Turner, D., Briken, P., & Rettenberger, M. (2021). Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses. SEX ABUSE-J RES TR, 33(4), 475-500. https://doi.org/10.1177/1079063220910723

Vancouver

Sauter J, Turner D, Briken P, Rettenberger M. Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses. SEX ABUSE-J RES TR. 2021 Jun;33(4):475-500. https://doi.org/10.1177/1079063220910723

Bibtex

@article{334793b0d32741f296856d97738b1a16,
title = "Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses",
abstract = "For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical characteristics and dynamic risk factors between persons receiving (+TLM, n = 38) versus not receiving (−TLM, n = 22) testosterone-lowering medications (TLMs). Individuals receiving TLM were more frequently diagnosed with paraphilic disorders. Neither the criminal history nor average risk scores differed between the two groups. In the +TLM, Stable-2007 scores showed a stronger decrease after TLM treatment was started. This accounted especially for the general and sexual self-regulation subscales. Individual variations in risk, however, were not predicted by TLM but were significantly related to treatment duration and Psychopathy Checklist–Revised (PCL-R) Factor I. Paraphilic patients with problems in self-regulatory abilities seem to profit most from pharmacological sex drive–reducing treatment. Furthermore, therapists seem to underestimate deviant sexual fantasies in medicated patients.",
author = "Julia Sauter and Daniel Turner and Peer Briken and Martin Rettenberger",
year = "2021",
month = jun,
doi = "10.1177/1079063220910723",
language = "English",
volume = "33",
pages = "475--500",
journal = "SEX ABUSE-J RES TR",
issn = "1079-0632",
publisher = "SAGE Publications",
number = "4",

}

RIS

TY - JOUR

T1 - Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses

AU - Sauter, Julia

AU - Turner, Daniel

AU - Briken, Peer

AU - Rettenberger, Martin

PY - 2021/6

Y1 - 2021/6

N2 - For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical characteristics and dynamic risk factors between persons receiving (+TLM, n = 38) versus not receiving (−TLM, n = 22) testosterone-lowering medications (TLMs). Individuals receiving TLM were more frequently diagnosed with paraphilic disorders. Neither the criminal history nor average risk scores differed between the two groups. In the +TLM, Stable-2007 scores showed a stronger decrease after TLM treatment was started. This accounted especially for the general and sexual self-regulation subscales. Individual variations in risk, however, were not predicted by TLM but were significantly related to treatment duration and Psychopathy Checklist–Revised (PCL-R) Factor I. Paraphilic patients with problems in self-regulatory abilities seem to profit most from pharmacological sex drive–reducing treatment. Furthermore, therapists seem to underestimate deviant sexual fantasies in medicated patients.

AB - For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical characteristics and dynamic risk factors between persons receiving (+TLM, n = 38) versus not receiving (−TLM, n = 22) testosterone-lowering medications (TLMs). Individuals receiving TLM were more frequently diagnosed with paraphilic disorders. Neither the criminal history nor average risk scores differed between the two groups. In the +TLM, Stable-2007 scores showed a stronger decrease after TLM treatment was started. This accounted especially for the general and sexual self-regulation subscales. Individual variations in risk, however, were not predicted by TLM but were significantly related to treatment duration and Psychopathy Checklist–Revised (PCL-R) Factor I. Paraphilic patients with problems in self-regulatory abilities seem to profit most from pharmacological sex drive–reducing treatment. Furthermore, therapists seem to underestimate deviant sexual fantasies in medicated patients.

U2 - 10.1177/1079063220910723

DO - 10.1177/1079063220910723

M3 - SCORING: Journal article

VL - 33

SP - 475

EP - 500

JO - SEX ABUSE-J RES TR

JF - SEX ABUSE-J RES TR

SN - 1079-0632

IS - 4

ER -